melatonin has been researched along with losartan potassium in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.85) | 18.2507 |
| 2000's | 4 (15.38) | 29.6817 |
| 2010's | 18 (69.23) | 24.3611 |
| 2020's | 3 (11.54) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Oveisi, F; Reyes, GA; Vaziri, ND; Zhou, XJ | 1 |
| Herrera, J; Nava, M; Rodríguez-Iturbe, B; Romero, F | 1 |
| Arias, C; Labonia, W; Rubio, D | 1 |
| Bednarek, N; Gressens, P; Sizonenko, SV | 1 |
| Franco-Bourland, RE; Grijalva, I; Guízar-Sahagún, G; Ibarra, A; Madrazo, I; Martínez-Cruz, A; Rodríguez-Balderas, CA | 1 |
| Cilio, MR; Ferriero, DM | 1 |
| Levene, MI | 1 |
| Miyamoto, Y | 1 |
| Acet, A; Kaya, E; Parlakpinar, H; Tasdemir, S; Vardi, N | 1 |
| Back, SA; Bennet, L; Derrick, M; Groenendaal, F; Gunn, AJ; Juul, SE; Mallard, C; Northington, F; Robertson, NJ; Tan, S; Valdez, RC; van Bel, F | 1 |
| Ahmadiasl, N; Alihemati, A; Azimian, E; Banaei, S; Baradaran, B | 1 |
| Ferriero, DM; Juul, SE | 1 |
| Banaei, S | 1 |
| Alonso-Alconada, D; Ezzati, M; Hassell, KJ; Hausenloy, DJ; Robertson, NJ | 1 |
| Barton, SK; Christoph-Roehr, C; Hooper, SB; Miller, SL; Moss, TJ; Polglase, GR; Schmölzer, GM; Tolcos, M; Wallace, EM | 1 |
| Juul, SE; McAdams, RM | 1 |
| Ahmadiasl, N; Alihemmati, A; Banaei, S | 1 |
| Firago, ME; Zinchuk, VV | 1 |
| Albrecht, M; Groenendaal, F; Peeters-Scholte, C; van Bel, F; Zitta, K | 1 |
| McNally, MA; Soul, JS | 1 |
| Cheung, PY; Schmölzer, GM; Solevåg, AL | 1 |
| Allami, HCA; Hadi Al Tukmagi, HF; Hameed, EN | 1 |
| Aceti, A; Austin, T; Corvaglia, L; Faldella, G; Martini, S | 1 |
| Borbélyová, V; Frajewicki, A; Jandová, K; Janišová, K; Khan, S; Laštůvka, Z; Mysliveček, J; Otáhal, J; Riljak, V | 1 |
| Burkhardt, C; Burton, VJ; Fouda, MA; Gerner, G; Hamimi, S; Jantzie, LL; Kitase, Y; Muthukumar, S; Northington, FJ; Robinson, S; Scafidi, J; Vasan, V; Ye, X | 1 |
14 review(s) available for melatonin and losartan potassium
| Article | Year |
|---|---|
Growth factors and plasticity.
Topics: Animals; Animals, Newborn; Brain; Clinical Trials as Topic; Erythropoietin; Humans; Intercellular Signaling Peptides and Proteins; Melatonin; Mice; Neuronal Plasticity; Neuroprotective Agents | 2007 |
Synergistic neuroprotective therapies with hypothermia.
Topics: Acetylcysteine; Anticonvulsants; Body Temperature; Cannabinoids; Combined Modality Therapy; Erythropoietin; Fructose; Humans; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Infant, Newborn; Levetiracetam; Melatonin; Neuroprotective Agents; Piracetam; Topiramate; Xenon | 2010 |
[Influences of general anesthetics on the developing mammalian brain].
Topics: Adrenergic alpha-2 Receptor Agonists; Anesthesia, General; Anesthetics, General; Animals; Apoptosis; Brain; Developmental Disabilities; Erythropoietin; Humans; Hypothermia, Induced; Infant; Infant, Newborn; Melatonin; Neurons; Xenon | 2011 |
Which neuroprotective agents are ready for bench to bedside translation in the newborn infant?
Topics: Allopurinol; Biopterins; Erythropoietin; Humans; Infant, Newborn; Melatonin; Neuroprotective Agents; Nitric Oxide Synthase Type I; Translational Research, Biomedical; Xenon | 2012 |
Pharmacologic neuroprotective strategies in neonatal brain injury.
Topics: Acetylcysteine; Allopurinol; Antioxidants; Ascorbic Acid; Biopterins; Erythropoietin; Excitatory Amino Acid Antagonists; Free Radical Scavengers; Fructose; Humans; Hypoxia-Ischemia, Brain; Infant, Extremely Premature; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Melatonin; Memantine; Neuroprotective Agents; Nitric Oxide Synthase Type III; Resveratrol; Stilbenes; Topiramate; Vitamin E; Xenon | 2014 |
Novel role of microRNAs in renal ischemia reperfusion injury.
Topics: Acute Kidney Injury; Animals; Apoptosis; Erythropoietin; Humans; Melatonin; Mice; MicroRNAs; Rats; Reactive Oxygen Species; Reperfusion Injury | 2015 |
New horizons for newborn brain protection: enhancing endogenous neuroprotection.
Topics: Asphyxia Neonatorum; Brain; Cannabinoids; Erythropoietin; Humans; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Infant, Newborn; Melatonin; Neuroprotection; Neuroprotective Agents | 2015 |
Ventilation-Induced Brain Injury in Preterm Neonates: A Review of Potential Therapies.
Topics: Brain Injuries; Delivery Rooms; Erythropoietin; Female; Glucocorticoids; Humans; Infant, Newborn; Infant, Premature; Intermittent Positive-Pressure Ventilation; Melatonin; Pregnancy; Prenatal Care; Randomized Controlled Trials as Topic; Respiratory Distress Syndrome, Newborn | 2016 |
Neonatal Encephalopathy: Update on Therapeutic Hypothermia and Other Novel Therapeutics.
Topics: Anesthetics, Inhalation; Biotin; Central Nervous System Depressants; Cerebral Palsy; Constriction; Erythropoietin; Humans; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Infant, Newborn; Intellectual Disability; Melatonin; Stem Cell Transplantation; Survival Rate; Umbilical Cord; Xenon | 2016 |
Neuroprotective strategies following perinatal hypoxia-ischemia: Taking aim at NOS.
Topics: Allopurinol; Asphyxia Neonatorum; Biotin; Cerebral Palsy; Clinical Trials as Topic; Epilepsy; Erythropoietin; Female; Humans; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Infant, Newborn; Intellectual Disability; Ischemic Postconditioning; Melatonin; Neuroprotective Agents; Pregnancy; Reactive Nitrogen Species; Reactive Oxygen Species | 2019 |
Pharmacologic Prevention and Treatment of Neonatal Brain Injury.
Topics: Adrenal Cortex Hormones; Allopurinol; Anesthetics, Inhalation; Anticonvulsants; Antioxidants; Cerebral Intraventricular Hemorrhage; Cyclooxygenase Inhibitors; Darbepoetin alfa; Erythropoietin; Free Radical Scavengers; Hematinics; Humans; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Indomethacin; Infant, Newborn; Leukomalacia, Periventricular; Magnesium; Melatonin; Neuroprotection; Prenatal Care; Topiramate; Xenon | 2019 |
Novel interventions to reduce oxidative-stress related brain injury in neonatal asphyxia.
Topics: Acetylcysteine; Allopurinol; Argon; Asphyxia Neonatorum; Cannabinoids; Erythropoietin; Female; Humans; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Infant, Newborn; Magnesium Sulfate; Melatonin; Neuroprotective Agents; Oxidative Stress; Pregnancy; Treatment Outcome; Xenon | 2019 |
Free radicals and neonatal encephalopathy: mechanisms of injury, biomarkers, and antioxidant treatment perspectives.
Topics: Acetylcysteine; Allopurinol; Animals; Antioxidants; Asphyxia Neonatorum; Biomarkers; Brain Injuries; Clinical Trials as Topic; DNA; Erythropoietin; Free Radicals; Humans; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Infant, Newborn; Malondialdehyde; Melatonin; Nitric Oxide; Oxidative Stress; Prostaglandins; Proteins; Uric Acid | 2020 |
Perinatal hypoxic-ischemic damage: review of the current treatment possibilities.
Topics: Central Nervous System Depressants; Erythropoietin; Female; Humans; Hypoxia; Hypoxia-Ischemia, Brain; Infant, Newborn; Melatonin; Pregnancy | 2020 |
3 trial(s) available for melatonin and losartan potassium
| Article | Year |
|---|---|
Melatonin prevents oxidative stress resulting from iron and erythropoietin administration.
Topics: Adult; Anemia; Catalase; Double-Blind Method; Erythrocytes; Erythropoietin; Female; Glutathione; Humans; Infusions, Intravenous; Iron; Kidney Failure, Chronic; Male; Malondialdehyde; Melatonin; Oxidative Stress; Placebos; Recombinant Proteins; Renal Dialysis; Treatment Outcome | 2001 |
Melatonin Improves Erythropoietin Hyporesponsiveness via Suppression of Inflammation.
Topics: Anemia; Antioxidants; Biomarkers; Erythropoietin; Female; Hematinics; Humans; Inflammation; Male; Melatonin; Middle Aged; Renal Insufficiency, Chronic | 2019 |
Infantile Cocktail of Erythropoietin and Melatonin Restores Gait in Adult Rats with Preterm Brain Injury.
Topics: Animals; Brain Injuries; Erythropoietin; Female; Gait; Humans; Infant; Melatonin; Pregnancy; Premature Birth; Rats | 2022 |
9 other study(ies) available for melatonin and losartan potassium
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Dysregulation of melatonin metabolism in chronic renal insufficiency: role of erythropoietin-deficiency anemia.
Topics: Anemia; Animals; Circadian Rhythm; Erythropoietin; Kidney Failure, Chronic; Light; Male; Melatonin; Pineal Gland; Rats; Rats, Sprague-Dawley | 1996 |
Melatonin corrects reticuloendothelial blockade and iron status in haemodialysed patients.
Topics: Adult; Aged; Aged, 80 and over; Erythropoietin; Female; Ferritins; Hematocrit; Hemoglobins; Humans; Iron; Iron-Dextran Complex; Kidney Failure, Chronic; Male; Melatonin; Middle Aged; Mononuclear Phagocyte System; Renal Dialysis; Transferrin | 2005 |
Lack of neuroprotection with pharmacological pretreatment in a paradigm for anticipated spinal cord lesions.
Topics: Analysis of Variance; Animals; Cyclosporine; Disease Models, Animal; Erythropoietin; Female; Locomotion; Melatonin; Methylprednisolone; Neuroprotective Agents; Postoperative Complications; Rats; Rats, Long-Evans; Recombinant Proteins; Recovery of Function; Spinal Cord; Spinal Cord Injuries; Time Factors | 2009 |
Cool treatment for birth asphyxia, but what's next?
Topics: Animals; Asphyxia Neonatorum; Combined Modality Therapy; Erythropoietin; Humans; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Infant, Newborn; Magnesium Sulfate; Melatonin; Neuroprotective Agents; Recombinant Proteins | 2010 |
Effect of endogen-exogenous melatonin and erythropoietin on dinitrobenzene sulfonic acid-induced colitis.
Topics: Animals; Anti-Inflammatory Agents; Benzenesulfonates; Caspase 3; CD4-Positive T-Lymphocytes; Colitis; Disease Models, Animal; Drug Therapy, Combination; Epithelial Cells; Erythropoietin; Flow Cytometry; Goblet Cells; Male; Melatonin; Rats; Rats, Wistar | 2013 |
Effect of a combined treatment with erythropoietin and melatonin on renal ischemia reperfusion injury in male rats.
Topics: Acute Kidney Injury; Animals; Anti-Inflammatory Agents; Antioxidants; Disease Models, Animal; Drug Therapy, Combination; Erythropoietin; Glutathione Peroxidase; Kidney; Male; Malondialdehyde; Melatonin; Models, Animal; Rats; Rats, Wistar; Reactive Oxygen Species; Reperfusion Injury; Superoxide Dismutase | 2014 |
Combination Anti-Apoptotic Effect of Erythropoietin and Melatonin on Ischemia Reperfusion-Induced Renal Injury in Rats.
Topics: Acute Kidney Injury; Animals; Antioxidants; Apoptosis; Epoetin Alfa; Erythropoietin; Glutathione Peroxidase; Male; Malondialdehyde; Melatonin; Rats; Rats, Wistar; Reperfusion Injury; Superoxide Dismutase | 2016 |
[Participation of melatonin in regulation of blood oxygen-transport function in oxidative stress induced by injection of lipopolisaccharide].
Topics: Animals; Antioxidants; Erythropoietin; Gasotransmitters; Lipid Peroxidation; Lipopolysaccharides; Melatonin; Oxidative Stress; Oxygen; Rats, Wistar | 2017 |